Head-to-head · Cost-Efficiency Index
Navio MD vs Revive Longevity
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Navio MD
Shoppers who want compounded tirzepatide with a brand-name fallback path on the same platform, 48 states.
Visit Navio MDRevive Longevity
Shoppers who want compounded tirzepatide from a program that names its pharmacy, and who don't need semaglutide.
Visit Revive LongevityThe verdict
Navio MD and Revive Longevity tie on the Cost-Efficiency Index at 73/100, so neither wins outright on the numbers, so choose on fit. Navio MD: Shoppers who want compounded tirzepatide with a brand-name fallback path on the same platform, 48 states. Revive Longevity: Shoppers who want compounded tirzepatide from a program that names its pharmacy, and who don't need semaglutide.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Navio MD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Navio MD | Revive Longevity |
|---|---|---|
| Cost-Efficiency Index | 73/100 | 73/100 |
| Semaglutide / mo | $345/moBrand Ozempic | Not offered |
| Tirzepatide / mo | $189/moStarting dose, compounded | $279Every 4 weeks (compounded, subscription you can cancel; $299 for a single month) |
| Semaglutide / yr (modeled) | $4,140 | — |
| Tirzepatide / yr (modeled) | $2,268 | $3,62713 charges |
| Coverage | 48 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #87 | #93 |
Navio MD
73/100Where the value is
- LegitScript certified with board-certified providers claimed
- Both compounded and brand-name options on one platform
- 48-state coverage with the two exclusions (AL, MS) explicitly disclosed rather than hidden
The tradeoffs
- No compounded semaglutide offered — only brand-name Ozempic for that molecule, at a much higher price than compounded competitors
- All prices are 'as low as' floors; the exact dose tied to each starting price is not published
Revive Longevity
73/100Where the value is
- Tirzepatide prices are on the product page before any questionnaire: $279 every four weeks on subscription, $299 for one month, or $749 for a three-month supply
- Names its compounding pharmacy, Strive Pharmacy in Gilbert, Arizona, and its clinical platform partner, Telegra MD
- Your card is only authorized at checkout, and the hold is released with no charge if a provider decides you aren't a candidate
The tradeoffs
- No semaglutide: tirzepatide is the only GLP-1 it sells
- The subscription bills every four weeks, which is 13 charges a year, or $3,627 at $279
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.